CN Stock MarketDetailed Quotes
002950 Allmed Medical Products
- 8.75
- -0.34-3.74%
Noon Break Dec 17 11:30 CST
5.54BMarket Cap24.58P/E (TTM)
9.11High8.74Low56.81KlotVolume9.08Open9.09Pre Close50.38MTurnover1.26%Turnover Ratio50.29P/E (Static)633.27MShares10.5252wk High1.66P/B3.95BFloat Cap5.9952wk Low10.00Limit Up452.00MShs Float38.96Historical High8.18Limit Down4.07%Amplitude5.99Historical Low0.03Dividend TTM8.87Avg Price34.24KlotAsk0.31%Div YieldTTM100Lot Size21.40KlotBid
Allmed Medical Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 11.37%2.47B | -1.85%1.55B | -12.22%774.75M | -39.35%2.78B | -35.30%2.22B | -31.28%1.57B | -22.98%882.61M | 45.07%4.59B | 59.28%3.43B | 75.12%2.29B |
| Refunds of taxes and levies | 13.13%153.29M | 16.59%111.05M | 17.71%60.32M | -47.35%136.98M | -39.06%135.5M | -19.07%95.25M | 7.46%51.24M | 57.65%260.17M | 82.03%222.34M | 40.01%117.69M |
| Cash received relating to other operating activities | 63.64%43.94M | 154.56%39.2M | 314.57%27.22M | -58.35%53.34M | -36.31%26.85M | -53.90%15.4M | -28.08%6.57M | -16.38%128.08M | -60.84%42.16M | -56.65%33.41M |
| Cash inflows from operating activities | 12.06%2.67B | 0.62%1.7B | -8.31%862.28M | -40.26%2.97B | -35.54%2.38B | -31.00%1.69B | -21.81%940.42M | 42.96%4.98B | 55.02%3.69B | 66.21%2.44B |
| Goods services cash paid | 16.45%1.6B | -8.69%994.27M | -30.25%493.48M | -38.66%1.75B | -33.14%1.38B | -20.68%1.09B | 19.14%707.49M | 26.68%2.85B | 33.90%2.06B | 38.75%1.37B |
| Staff behalf paid | -3.96%417.98M | -6.54%287.88M | -14.78%143.41M | -10.14%554.19M | -6.60%435.23M | -1.69%308.04M | 10.56%168.29M | 21.94%616.72M | 16.34%465.97M | 24.53%313.34M |
| All taxes paid | 4.01%41.4M | -23.85%26.42M | -85.22%9.05M | -23.52%126.64M | -70.72%39.81M | -66.73%34.69M | -14.38%61.28M | 3.61%165.6M | 1.34%135.95M | -5.92%104.27M |
| Cash paid relating to other operating activities | 27.60%86.8M | 28.29%60.2M | 29.30%28.55M | -37.92%122.32M | -47.24%68.02M | -49.69%46.93M | -59.27%22.08M | 2.09%197.03M | 88.12%128.92M | 94.77%93.27M |
| Cash outflows from operating activities | 11.96%2.15B | -7.42%1.37B | -29.68%674.5M | -33.37%2.55B | -31.19%1.92B | -21.51%1.48B | 10.02%959.14M | 23.20%3.83B | 30.31%2.79B | 34.58%1.88B |
| Net cash flows from operating activities | 12.51%516.7M | 58.08%327.17M | 1,102.93%187.78M | -63.16%423.5M | -49.02%459.26M | -62.99%206.96M | -105.66%-18.72M | 206.71%1.15B | 275.58%900.86M | 698.05%559.15M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -94.85%10.64M | -95.62%9.24M | -97.47%3.49M | -76.66%350.99M | -75.80%206.78M | -63.78%210.93M | 12.27%137.76M | -48.13%1.5B | -55.16%854.54M | -61.32%582.37M |
| Cash received from returns on investments | 170.00%398.17K | 170.00%398.17K | ---- | 696.43%2.8M | -58.00%147.47K | -58.00%147.47K | ---- | 232.50%351.12K | -98.54%351.12K | -97.76%351.12K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1,054.76%9.02M | -98.01%15.45K | -91.38%3.45K | -78.73%773.69K | -85.24%780.72K | -85.15%778.32K | -99.24%40K | -49.07%3.64M | 38.42%5.29M | 5,137.50%5.24M |
| Cash inflows from investing activities | -90.34%20.05M | -95.44%9.66M | -97.47%3.49M | -76.49%354.56M | -75.85%207.71M | -63.97%211.86M | 7.70%137.8M | -48.13%1.51B | -55.86%860.18M | -61.35%587.96M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -40.73%115.67M | -42.79%78.2M | -57.56%41.38M | -28.03%286.48M | -56.23%195.17M | -49.57%136.7M | 26.80%97.51M | 36.93%398.05M | 9.50%445.94M | -25.29%271.08M |
| Cash paid to acquire investments | -99.21%1.27M | -99.13%1.27M | -97.90%1.27M | -89.31%211.53M | -89.16%160.53M | -88.09%146.53M | -90.97%60.53M | -33.66%1.98B | -40.33%1.48B | -35.26%1.23B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.08%99.07M | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | 2,970.23%72M | ---- | ---- | ---- | -84.70%2.35M | ---- | ---- |
| Cash outflows from investing activities | -67.12%116.94M | -71.94%79.47M | -73.01%42.65M | -77.00%570.02M | -81.54%355.7M | -81.13%283.23M | -78.84%158.04M | -26.67%2.48B | -33.30%1.93B | -33.66%1.5B |
| Net cash flows from investing activities | 34.53%-96.89M | 2.19%-69.82M | -93.43%-39.16M | 77.80%-215.46M | 86.13%-147.99M | 92.19%-71.38M | 96.73%-20.25M | -105.13%-970.52M | -13.38%-1.07B | -23.16%-913.37M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --600K | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --600K | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -51.82%384.09M | -53.17%299.32M | -60.43%119.95M | -47.91%1.31B | -51.47%797.19M | -49.81%639.24M | -39.75%303.15M | -21.98%2.52B | -11.27%1.64B | -18.16%1.27B |
| Cash received relating to other financing activities | -62.92%7.05M | -86.60%2.55M | -86.60%2.55M | -35.08%252.76M | --19M | --19M | --19M | --389.31M | ---- | ---- |
| Cash inflows from financing activities | -52.00%391.73M | -54.05%302.47M | -61.97%122.5M | -46.20%1.56B | -50.31%816.19M | -48.32%658.24M | -35.97%322.15M | -9.92%2.91B | -11.29%1.64B | -18.18%1.27B |
| Borrowing repayment | -61.19%456.67M | -59.28%354.16M | -59.39%198.87M | -48.94%1.52B | -31.44%1.18B | -18.56%869.72M | 17.24%489.71M | -6.56%2.97B | 6.11%1.72B | -10.74%1.07B |
| Dividend interest payment | -40.99%35.64M | -41.73%31.59M | -49.16%4.91M | -60.21%65.21M | -59.95%60.39M | -62.20%54.21M | 523.82%9.66M | -71.60%163.9M | -72.47%150.78M | -74.73%143.41M |
| Cash payments relating to other financing activities | 5,418.36%100.59M | 10,656.86%99.77M | -77.82%892.59K | 3,812.52%310.42M | -85.50%1.82M | -95.52%927.53K | -77.93%4.02M | -64.49%7.93M | --12.57M | --20.72M |
| Cash outflows from financing activities | -52.14%592.89M | -47.50%485.52M | -59.34%204.67M | -39.78%1.89B | -34.09%1.24B | -24.94%924.85M | 15.06%503.39M | -16.83%3.14B | -13.19%1.88B | -30.15%1.23B |
| Net cash flows from financing activities | 52.40%-201.16M | 31.34%-183.05M | 54.66%-82.17M | -39.08%-328.81M | -78.35%-422.57M | -742.16%-266.61M | -375.92%-181.24M | 57.23%-236.41M | 24.41%-236.93M | 120.02%41.52M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -195.24%-1.95M | -13.35%2.53M | 149.20%982.08K | 107.36%7.55M | -90.10%2.04M | -80.59%2.92M | -48.48%-2M | -960.04%-102.64M | 1,396.51%20.63M | 2,198.81%15.05M |
| Net increase in cash and cash equivalents | 298.36%216.72M | 159.98%76.84M | 130.35%67.43M | 29.18%-113.21M | 71.44%-109.26M | 56.96%-128.1M | 0.65%-222.2M | 74.99%-159.85M | 62.25%-382.61M | 66.16%-297.65M |
| Add:Begin period cash and cash equivalents | -22.51%389.7M | -22.51%389.7M | -22.51%389.7M | -24.12%502.91M | -24.12%502.91M | -24.12%502.91M | -24.12%502.91M | -49.09%662.76M | -49.09%662.76M | -49.09%662.76M |
| End period cash equivalent | 54.05%606.42M | 24.48%466.54M | 62.85%457.14M | -22.51%389.7M | 40.52%393.66M | 2.66%374.81M | -36.07%280.71M | -24.12%502.91M | -2.86%280.15M | -13.53%365.11M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
